Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.
Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.
The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.
Publications found:
69,579
Sort by:
Essential Tremor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Essential Tremor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Essential Tremor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Player...
May 2022
48 pages
Exocrine Pancreatic Insufficiency Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Exocrine Pancreatic Insufficiency Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Exocrine Pancreatic Insufficiency Drugs in Development by Stages, Target, MoA,...
May 2022
36 pages
Extrahepatic Bile Duct Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Extrahepatic Bile Duct Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Extrahepatic Bile Duct Cancer Drugs in Development by Stages, Target, MoA, RoA, Mo...
May 2022
51 pages
Familial Amyloid Cardiomyopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Familial Amyloid Cardiomyopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Familial Amyloid Cardiomyopathy Drugs in Development by Stages, Target, MoA, RoA...
May 2022
37 pages
Fatty Liver Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,500.00
Fatty Liver Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Fatty Liver Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key...
May 2022
184 pages
Febrile Neutropenia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Febrile Neutropenia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Febrile Neutropenia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key...
May 2022
47 pages
Fecal Incontinence Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Fecal Incontinence Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Fecal Incontinence Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pl...
May 2022
37 pages
Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview...
May 2022
41 pages
Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,500.00
Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an ov...
May 2022
214 pages
Flavivirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,500.00
Flavivirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Flavivirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and...
May 2022
277 pages
Follicular Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,500.00
Follicular Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Follicular Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key...
May 2022
323 pages
Follicular Thyroid Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Follicular Thyroid Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Follicular Thyroid Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule T...
May 2022
52 pages
Food Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Food Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Food Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provid...
May 2022
99 pages
Fungal Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,500.00
Fungal Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Fungal Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...
May 2022
243 pages
Fungal Keratitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Fungal Keratitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Fungal Keratitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Player...
May 2022
36 pages
Gastric Motility Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Gastric Motility Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Gastric Motility Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule T...
May 2022
36 pages
Gastrointestinal Radiation Toxicity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Gastrointestinal Radiation Toxicity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Gastrointestinal Radiation Toxicity Drugs in Development by Stages, Target,...
May 2022
38 pages
Gastroparesis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Gastroparesis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Gastroparesis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players prov...
May 2022
48 pages
Gaucher Disease Type I Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Gaucher Disease Type I Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Gaucher Disease Type I Drugs in Development by Stages, Target, MoA, RoA, Molecule Type an...
May 2022
46 pages
Gaucher Disease Type II Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Gaucher Disease Type II Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Gaucher Disease Type II Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...
May 2022
35 pages
Gaucher Disease Type III Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Gaucher Disease Type III Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Gaucher Disease Type III Drugs in Development by Stages, Target, MoA, RoA, Molecule Typ...
May 2022
41 pages
